Table 2.
Treatment group | Worm burden | Worm-reduction rate (%) | Average number of eggs/1 g liver tissue (× 103) | Liver egg-reduction rate (%) |
---|---|---|---|---|
Infected-control | 27.95 ± 2.82 | Not applicable | 23.42 ± 7.91 | Not applicable |
Anti-CTLA-4 mAb | 21.87 ± 3.53 | 21.75*# | 19.0 ± 5.36 | 18.89*# |
FABP | 20.52 ± 4.62 | 26.58*# | 16.10 ± 6.58 | 31.24*# |
Combination | 12.69 ± 1.46 | 54.61* | 9.54 ± 5.67 | 59.25* |
The worm burden was evaluated via the portal-vein infusion method, and the worm-reduction rate was calculated. Livers were removed from the mice in the infected groups after sacrifice, and digested with 5% potassium hydroxide. The number of eggs in an 1-ml aliquot of each digested sample was then counted, and the liver egg-reduction rate were calculated. Data are presented as the mean ± S.D from three independent combined experiments (n = 8/group).
P < 0.05 compared to the infected-control group.
P < 0.05 compared to the combination group.
Anti-CTLA-4 mAb, anti-CTLA-4 monoclonal antibody.